Genotypic influences on severity of exudative age-related macular degeneration

Invest Ophthalmol Vis Sci. 2010 May;51(5):2620-5. doi: 10.1167/iovs.09-4423. Epub 2009 Dec 30.

Abstract

Purpose: Major genetic risk factors have recently been identified for age-related macular degeneration (AMD), including the ARMS2/LOC387715 and CFH at-risk polymorphisms. The study was conducted to establish correlations between the AMD genotype and both the phenotype and severity of AMD.

Methods: In a prospective cohort of 1216 AMD patients, four genotypic homozygous groups were identified (n = 264): double homozygous for wild-type alleles (group 1, n = 49), homozygous for the at-risk allele of ARMS2/LOC387715 only (group 2, n = 57), homozygous for the at-risk allele of CFH only (group 3, n = 106), and double homozygous for both at-risk alleles (group 4, n = 52). The phenotypic classification of exudative AMD was based on fluorescein angiography.

Results: Mean age at presentation was significantly lower in group 4 than in group 1 (P < 0.014). Patients in group 4 presented more often with bilateral CNV and fibrovascular scars than did patients in group 1 (P < 0.001 and < 0.0031 respectively) and with significantly lower visual acuity (VA) in the first affected eye than did patients in group 1 (P < 0.02). Patients in group 2 presented with worse VA than did patients in group 3 (P < 0.003). Classic CNV was more commonly associated with the at-risk allele of the ARMS2/LOC387715 locus than with the at-risk allele of the CFH gene (P < 0.026).

Conclusions: This study demonstrates an association between the at-risk allele of the ARMS2/LOC387715 locus and classic CNV, fibrovascular lesions, and poor VA. Individuals double homozygous for both at-risk alleles had a higher risk of being affected with a severe form of AMD at an earlier age.

MeSH terms

  • Aged
  • Aged, 80 and over
  • Alleles
  • Complement Factor H / genetics
  • Exudates and Transudates
  • Female
  • Fluorescein Angiography
  • Genotype
  • Humans
  • Macular Degeneration / genetics*
  • Male
  • Phenotype
  • Polymerase Chain Reaction
  • Polymorphism, Single Nucleotide*
  • Prospective Studies
  • Proteins / genetics*
  • Severity of Illness Index
  • Visual Acuity

Substances

  • ARMS2 protein, human
  • CFH protein, human
  • Proteins
  • Complement Factor H